Research output

  1. Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Reply to “Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma”

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  3. The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good?

    Research output: Contribution to journal › Article › Academic › peer-review

View all (6) »

ID: 5454689